BioRestorative Therapies, Inc. (BRTX) vs Evogene Ltd. (EVGN)
A side-by-side comparison of BioRestorative Therapies, Inc. and Evogene Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRTX
BioRestorative Therapies, Inc.
$2.25HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
EVGN
Evogene Ltd.
$0.44HealthcareDelayed quote: Oct 6, 2026, 2:51 PM EDT
Total return — BRTX vs EVGN
growth of $100 · dividends reinvested · last 10yBRTX -100.0% (-69.0%/yr)EVGN -99.4% (-39.7%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
BRTX EVGN
BRTX vs EVGN: by the numbers
- •EVGN is the larger company ($4M vs $3M market cap).
- •Both run net losses; EVGN's is the smaller (-694.19% vs -3089.55% net margin).
- •BRTX grew revenue faster over the past five years (38.99% vs 2.86% CAGR).
Metrics side by side
Valuation
| Metric | BRTX | EVGN |
|---|---|---|
| P/S ratio | 8.66 | 2.90 |
| P/B ratio | 1.02 | N/A |
Profitability
| Metric | BRTX | EVGN |
|---|---|---|
| Gross margin | 92.09% | -6.25% |
| Operating margin | -4350.05% | -364.24% |
| Net margin | -3089.55% | -694.19% |
| ROE | -365.43% | N/A |
| ROIC | -464.86% | -130.12% |
Growth (annualized)
| Metric | BRTX | EVGN |
|---|---|---|
| Revenue CAGR (5Y) | 38.99% | 2.86% |
| Total return CAGR (5Y) | -61.44% | -56.46% |
Frequently asked
- Which has grown faster, BRTX or EVGN?
- Over the past five years, BRTX grew revenue faster — BRTX at a 38.99% CAGR versus EVGN at 2.86%.
- How have BRTX and EVGN total returns compared?
- Over the past 10 years, BRTX delivered -68.97% and EVGN delivered -39.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioRestorative Therapies ROEEvogene ROEBioRestorative Therapies operating marginEvogene operating marginBioRestorative Therapies revenue growthEvogene revenue growthBioRestorative Therapies free cash flowEvogene free cash flow
BioRestorative Therapies & Evogene appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.